Human papillomavirus and other biomarkers in neck masses of unknown origin and in head and neck cancer
Author: Sivars, Lars
Date: 2018-05-09
Location: Föreläsningssalen, Cancer Centrum Karolinska, R8:00, Karolinska University Hospital, Solna
Time: 09.30
Department: Inst för onkologi-patologi / Dept of Oncology-Pathology
View/ Open:
Thesis (667.1Kb)
Abstract
Background. Human papillomavirus (HPV) is, in addition to smoking and alcohol, a risk factor for developing oropharyngeal squamous cell carcinoma (OPSCC), and more specifically tonsillar- and base of tongue squamous cell carcinoma (TSCC & BOTSCC respectively). Interestingly, HPV-positive (HPV+) TSCC/BOTSCC has a remarkably better clinical outcome than HPV-negative (HPV-) TSCC/BOTSCC and head and neck cancer in general. However, the role of HPV and other biomarkers in cancer of unknown primary in the head and neck region (HNCUP), i.e. where only a lymph node metastasis and no primary tumour is found, is not well understood. Moreover, the genetic landscape of HPV-positive HNCUP and the prognostic implications of certain mutations in TSCC/BOTSCC has not been studied extensively. Furthermore, using fine-needle aspiration cytology (FNAC) from neck masses for HPV-detection and potentially for predicting an HPV-positive TSCC/BOTSCC as the final diagnosis would be highly clinically useful, but has not been studied prospectively in a cohort consisting of both malignant and benign neck masses.
Aims. To investigate HPV DNA and mRNA and other prognostic biomarkers (p16, p53, CD8+ tumour infiltrating lymphocytes (TILs), HLA Class I expression) in HNCUP in relation to clinical outcome. Moreover, to study mutations in HPV+ HNCUP and TSCC/BOTSCC in relation to prognosis and to analyse whether HPV-detection in FNAC from neck masses is reliable and if a finding of HPV could predict an HPV+ TSCC/BOTSCC as the final diagnosis.
Results. In Paper I, we show that HPV is a favourable prognostic factor in HNCUP, and in Paper II, we validate this finding in a separate cohort (3-year overall survival 86% vs. 54% for HPV+ and HPV- HNCUP respectively, in the combined cohorts). In Paper II, we also demonstrate that HPV mRNA is expressed in the vast majority of HPV DNA+ HNCUP. Moreover, in Paper I we find that high p53-expression correlates to a poor prognosis, and in Paper II that a low number of CD8+ TILs are potentially related to a poor outcome, while HLA Class I expression does not appear to be a prognostic factor in HNCUP. In Paper III, we show that TP53, CDKN2A and PIK3CA are the most commonly mutated genes in HPV+ HNCUP, and that having a mutation in FGFR3 correlated to a poor prognosis in HPV+ TSCC/BOTSCC. In Paper IV, we demonstrate that HPV DNA detection in FNAC from neck masses of unknown origin is reliable and could be used prospectively to predict an HPV+ TSCC/BOTSCC as the final diagnosis. HPV DNA was not found in malignant conditions other than HPV+ TSCC/BOTSCC or in any benign conditions, including branchial cleft cysts.
Conclusions. HPV appears to have a similar causative and prognostic role in HNCUP as in TSCC/BOTSCC. Investigation of HPV-status should therefore be part of the diagnostic work-up of an HNCUP. Examination of HPV DNA-status using FNAC is useful in the clinical investigation of patients with neck masses of unknown origins, including patients eventually diagnosed with HNCUP or TSCC/BOTSCC.
Aims. To investigate HPV DNA and mRNA and other prognostic biomarkers (p16, p53, CD8+ tumour infiltrating lymphocytes (TILs), HLA Class I expression) in HNCUP in relation to clinical outcome. Moreover, to study mutations in HPV+ HNCUP and TSCC/BOTSCC in relation to prognosis and to analyse whether HPV-detection in FNAC from neck masses is reliable and if a finding of HPV could predict an HPV+ TSCC/BOTSCC as the final diagnosis.
Results. In Paper I, we show that HPV is a favourable prognostic factor in HNCUP, and in Paper II, we validate this finding in a separate cohort (3-year overall survival 86% vs. 54% for HPV+ and HPV- HNCUP respectively, in the combined cohorts). In Paper II, we also demonstrate that HPV mRNA is expressed in the vast majority of HPV DNA+ HNCUP. Moreover, in Paper I we find that high p53-expression correlates to a poor prognosis, and in Paper II that a low number of CD8+ TILs are potentially related to a poor outcome, while HLA Class I expression does not appear to be a prognostic factor in HNCUP. In Paper III, we show that TP53, CDKN2A and PIK3CA are the most commonly mutated genes in HPV+ HNCUP, and that having a mutation in FGFR3 correlated to a poor prognosis in HPV+ TSCC/BOTSCC. In Paper IV, we demonstrate that HPV DNA detection in FNAC from neck masses of unknown origin is reliable and could be used prospectively to predict an HPV+ TSCC/BOTSCC as the final diagnosis. HPV DNA was not found in malignant conditions other than HPV+ TSCC/BOTSCC or in any benign conditions, including branchial cleft cysts.
Conclusions. HPV appears to have a similar causative and prognostic role in HNCUP as in TSCC/BOTSCC. Investigation of HPV-status should therefore be part of the diagnostic work-up of an HNCUP. Examination of HPV DNA-status using FNAC is useful in the clinical investigation of patients with neck masses of unknown origins, including patients eventually diagnosed with HNCUP or TSCC/BOTSCC.
List of papers:
I. Sivars L, Näsman A, Tertipis N, Vlastos A, Ramqvist T, Dalianis T, Munck-Wikland E, Nordemar S. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med. 2014 Apr;3(2):376-84.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sivars L, Landin D, Grün N, Vlastos A, Marklund L, Nordemar S, Ramqvist T, Munck-Wikland E, Näsman A, Dalianis T. Validation of human papillomavirus as a favourable prognostic marker and analysis of CD8+ tumour-infiltrating lymphocytes and other biomarkers in cancer of unknown primary in the head and neck region. Anticancer Res. 2017 Feb;37(2):665-673.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ährlund-Richter A, Tertipis N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3. Oncotarget. 2017 May 23;8(21):35339-35350.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Sivars L, Landin D, Haeggblom L, Tertipis N, Grün N, Bersani C, Marklund L, Ghaderi M, Näsman A, Ramqvist T, Nordfors C, Munck-Wikland E, Tani E, Dalianis T. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study. Head Neck. 2017 Mar;39(3):419-426.
Fulltext (DOI)
Pubmed
View record in Web of Science®
I. Sivars L, Näsman A, Tertipis N, Vlastos A, Ramqvist T, Dalianis T, Munck-Wikland E, Nordemar S. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med. 2014 Apr;3(2):376-84.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sivars L, Landin D, Grün N, Vlastos A, Marklund L, Nordemar S, Ramqvist T, Munck-Wikland E, Näsman A, Dalianis T. Validation of human papillomavirus as a favourable prognostic marker and analysis of CD8+ tumour-infiltrating lymphocytes and other biomarkers in cancer of unknown primary in the head and neck region. Anticancer Res. 2017 Feb;37(2):665-673.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ährlund-Richter A, Tertipis N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3. Oncotarget. 2017 May 23;8(21):35339-35350.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Sivars L, Landin D, Haeggblom L, Tertipis N, Grün N, Bersani C, Marklund L, Ghaderi M, Näsman A, Ramqvist T, Nordfors C, Munck-Wikland E, Tani E, Dalianis T. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study. Head Neck. 2017 Mar;39(3):419-426.
Fulltext (DOI)
Pubmed
View record in Web of Science®
Institution: Karolinska Institutet
Supervisor: Dalianis, Tina
Co-supervisor: Ramqvist, Torbjörn; Näsman, Anders; Munck-Wikland, Eva
Issue date: 2018-04-13
Rights:
Publication year: 2018
ISBN: 978-91-7831-032-6
Statistics
Total Visits
Views | |
---|---|
Human ... | 673 |
Human ...(legacy) | 651 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Human ... | 12 | 15 | 10 | 9 | 9 | 15 | 22 |
File Visits
Views | |
---|---|
Thesis_Lars_Sivars.pdf | 1419 |
Thesis_Lars_Sivars.pdf(legacy) | 430 |
null(legacy) | 2 |
Top country views
Views | |
---|---|
Sweden | 474 |
United States | 142 |
Denmark | 128 |
Ireland | 79 |
Australia | 70 |
Germany | 58 |
China | 53 |
India | 21 |
United Kingdom | 15 |
France | 14 |
Top cities views
Views | |
---|---|
Lane | 86 |
Dublin | 79 |
Ashburn | 64 |
Sydney | 64 |
Copenhagen | 60 |
Stockholm | 53 |
Sundbyberg | 45 |
Beijing | 23 |
Stocksund | 20 |
Hebei | 9 |